NCT06128343 2026-03-19
BACAP-2
University Hospital, Toulouse
Recruiting
Clinical Trials
15 trialsNCT06902545 2026-03-11
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
Astellas Pharma Inc
Recruiting
NCT00349830 2026-02-10
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University
Recruiting
NCT05892926 2025-07-20
HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia
AstraZeneca
Completed
NCT02818829 2025-03-21
BACAP
University Hospital, Toulouse
Active not recruiting
NCT06599749 2024-09-19
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)
University Hospital, Basel, Switzerland
Completed
NCT06405035 2024-05-08
MIMETIC
European Institute of Oncology
Recruiting
NCT05968196 2023-08-01
HCC and FTC
The Catholic University of Korea
Completed
NCT03578939 2021-03-18
LAPC-NGS-A/001
Istituto Clinico Humanitas
Completed
NCT01703650 2020-10-08
Role of Perfusion CT in Pancreatic Cancer
Seoul National University Hospital
Unknown
NCT00507702 2019-04-18
Identification of Key Blood Molecular Markers for Immunotherapy
Stanford University
Terminated
NCT01148082 2017-06-26
School Response to Families Who Have Children With Cancer
Stanford University
Withdrawn
NCT01837173 2013-04-23
ECLNI-MC
University Hospital, Gasthuisberg
Unknown
NCT00547742 2010-07-20
Correlation of PET-CT Studies With Serum Protein Analysis
Stanford University
Completed
NCT01135823 2010-06-03
Symptom Assessment With Patient Surveys
Stanford University
Completed